Whether you're a biotech racing toward your next milestone or a pharma managing complex global trials, this is the rare disease recruitment summit you can’t afford to miss. From AI-driven enrollment to advocacy-led retention, discover the partnerships and strategies that deliver measurable impact - no matter your size, scope, or stage.
Having trouble downloading the brochure? Let us know and we'll email it you instead
Download Here:
Reducing recruitment costs and boosting ROI by harnessing AI to rapidly identify and accurately target eligible rare disease patients, cutting enrollment timelines and minimizing screen failures.
Charles Shiner, Associate Vice President, Gene Therapy Marketing, Rocket Pharmaceuticals
Navigating decentralized trials in rare disease - identifying what works, tackling challenges, and balancing virtual convenience with medical oversight.
Matt Hay, U.S. Director of Advocacy for Metabolics - Neurofibromatosis (NF) and Hypophosphatasia (HPP), Alexion Pharmaceuticals
Planning for retention by embedding patient-friendly reimbursement and support strategies early - overcoming cross-border challenges, enhancing patient care with concierge and home nursing services, and simplifying communication to reduce stress.
Deborah Micklos, Senior Clinical Operations Director, Inventiva
From identifying rare patients using AI and global registries to enrolling, reimbursing, and retaining them, discover comprehensive, end-to-end strategies to overcome recruitment challenges.
Experience immersive, interactive workshops that go beyond presentations - enabling you to co-create solutions, share experiences, and leave with ready-to-use strategies.
Network with over 70 experts, patient advocates, CROs, and innovators focused on accelerating rare disease trial recruitment.
Explore the transformative impact of remote monitoring and decentralized study models in making rare disease trials more accessible and patient-friendly worldwide.
New Companies Confirmed for 2025:
